The Brigham and Dana-Farber Board Review in Oncology 2018-Videos+PDFs

The Brigham and Dana-Farber Board Review in Hematology 2018-Videos+PDF

Login is required

login

If you are not our user, for invitation Click Here

OakStone Price $1295

Date of Original Release: June 30, 2018
Termination Date: June 30, 2021

File size : 2.06 Gb

Brigham and Women’s Hospital Board Review

Prepare for your medical oncology board exam with this in-depth CME program. Ideal for MOC.

Earn CME Credit with this Board Review in Oncology

The Brigham and Dana-Farber Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will enhance patient care while you prep for the board exam by learning to:

  • Apply recommended oncology guidelines in clinical practice
  • Perform differential diagnosis of complex oncologic disorders
  • Identify and apply current therapeutic options for oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to oncology
  • Illustrate knowledge of pathophysiology as it applies to management of oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification oncology examinations

Topics/Speakers

  • Molecular Genetics of Cancer – Nikhil Wagle, MD
  • Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients – Lindsey Baden, MD
  • Symptom Management in Patients with Cancer – Janet L. Abrahm, MD
  • Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD
  • Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
  • Acute Leukemias – Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome – David P. Steensma, MD
  • Chronic Myelogenous Leukemia – Joseph H. Antin, MD
  • Myeloproliferative Syndromes – Ann M. Mullally, MD
  • Multiple Myeloma – Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulinemia, Amyloidosis – Irene M. Ghobrial, MD
  • Low Grade Lymphomas – Caron A. Jacobson, MD
  • High Grade Lymphomas – Eric D. Jacobsen, MD
  • Hodgkin’s Lymphoma – Ann S. LaCasce, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
  • Head and Neck Cancer – Robert I. Haddad, MD
  • Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer – Mark Awad, MD, PhD
  • Mesothelioma and Thymoma – David M. Jackman, MD
  • Thyroid Cancer – Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer – Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD
  • Anal Cancers – Robert J. Mayer, MD
  • Colorectal Cancers – Robert J. Mayer, MD
  • Gastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD
  • Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD
  • Renal and Bladder Cancer – Toni K. Choueiri, MD
  • Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
  • Melanoma – F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD
  • Ovarian Cancer – Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology – David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH
  • Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD
  • Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD
  • Breast Cancer Survivorship – Ann H. Partridge, MD, MPH